An endocrinology email list is a verified database of licensed endocrinologists, diabetes educators, reproductive endocrinologists, and metabolic medicine specialists, built from conference and CME partnerships, state and national medical associations, healthcare publication networks, and B2B2C matching and verification programs. SparkDBi maintains 19,062 verified US endocrinology contacts across 6 subspecialties.
Trusted by Revenue and Data Teams at
SparkDBi maintains a verified endocrinology email list covering 19,062 endocrinologists, diabetes educators, reproductive endocrinologists, and metabolic medicine specialists across the United States. Every contact is sourced from multiple vetted channels including conference and CME partnerships, state and national professional associations, and healthcare publication networks, then validated through email inbox verification, phone validation, and physical address confirmation before delivery. The database refreshes monthly.
Endocrinology sits at the centre of two of the fastest-growing drug categories in all of pharma. GLP-1 receptor agonists and SGLT2 inhibitors have reshaped diabetes and metabolic disease treatment over the past five years, and endocrinologists are the specialist gatekeepers for the highest-acuity patients in both categories. For pharmaceutical companies in these categories, reaching the right endocrinologist at the right institution is a direct commercial priority.
Who Uses the Endocrinology Email List
Pharmaceutical companies with diabetes, obesity, and metabolic disease pipelines are the dominant buyer. GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) and SGLT2 inhibitors (dapagliflozin, empagliflozin, canagliflozin) both require endocrinologist outreach for disease management education, patient selection criteria, and formulary conversations. These are among the highest-revenue drug categories in pharma, creating sustained demand for verified endocrinologist contact data.
Thyroid disease drug companies use the endocrinology list for outreach to endocrinologists managing hypothyroidism (levothyroxine, liothyronine), hyperthyroidism (methimazole, propylthiouracil), and thyroid cancer (lenvatinib, sorafenib, cabozantinib). Radioactive iodine treatment decisions also involve endocrinologists at specialist centres.
Medical device companies selling continuous glucose monitoring (CGM) systems (Dexcom, Abbott FreeStyle Libre), insulin pumps (Medtronic MiniMed, Tandem Diabetes Care), and closed-loop insulin delivery systems use the list for outreach to endocrinologists who initiate and manage device-based diabetes therapy.
Fertility clinics and IVF drug companies target reproductive endocrinologists for outreach on ovarian stimulation protocols (gonadotropins, GnRH agonists), progesterone supplementation, and infertility diagnostics.
CME and medical education providers use the endocrinology list for event promotion and clinical content distribution, given the high pace of change in diabetes and metabolic medicine guidelines.
Request Endocrinology Email List Contact Data
Subspecialty filters, geography, sample records available
Endocrinology Email List Subspecialties and Verified Contacts
The SparkDBi endocrinology database covers 6 subspecialties. All subspecialties are available as individual segments or combined with subspecialty flags.
| Subspecialty | Provider Type | Contacts |
|---|---|---|
| Endocrinologist, Diabetes & Metabolism | Physician | 8,908 |
| Diabetes Educator | Healthcare Professional | 3,098 |
| Reproductive Endocrinologist | Physician | 1,804 |
| Registered Nurse - Diabetes Educator | Nurse | 1,221 |
| Pediatrics - Endocrinologist | Physician | 1,049 |
| Registered Nurse - Reproductive Endocrinologist/Infertility | Nurse | 12 |
Key Drugs, Devices and Conditions in Endocrinology
Type 2 diabetes and obesity are the highest-volume commercial targets in endocrinology. Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity) all require endocrinologist engagement for complex patients who need specialist-level management beyond primary care. SGLT2 inhibitors (dapagliflozin, empagliflozin, canagliflozin) have added renal and cardiovascular indications that further expanded the prescribing base into endocrinology.
Type 1 diabetes management involves insulin formulations (aspart, lispro, glargine, degludec), CGM integration, and closed-loop systems. Endocrinologists managing Type 1 patients are the primary audience for insulin analogue companies, CGM manufacturers, and insulin pump vendors. The artificial pancreas category (Medtronic 780G, Omnipod 5, Tandem Control-IQ) has created new competition in device-based diabetes management.
Thyroid disorders including hypothyroidism, hyperthyroidism, Graves disease, and thyroid cancer are a significant subspecialty area. Levothyroxine remains one of the most prescribed medications in the US, and thyroid cancer treatments (lenvatinib, sorafenib, vandetanib, cabozantinib) are an active commercial focus for oncology-endocrinology crossover programs.
Reproductive endocrinology covers infertility treatment, PCOS, and reproductive hormone management. Gonadotropins (follitropin, menotropins), GnRH agonists and antagonists, and letrozole for ovulation induction are the primary drug categories targeting reproductive endocrinologists.
How SparkDBi Sources and Verifies HCP Data
SparkDBi builds its HCP contact database from multiple vetted channels. Primary sources include conference attendance and CME event participation records from healthcare education partners, member directories from state and national professional associations, subscriber and contributor lists from healthcare publication networks, and B2B2C data matching and verification partnerships.
Publicly available sources including CMS and NPPES records are used as a cross-reference and comparison tool only. They are not a primary data source. CMS and NPPES data is frequently stale or out of date for direct contact purposes. SparkDBi treats it as one reference point among many rather than a source of record.
Verification runs across three dimensions. Email inbox verification connects directly to the receiving mail server and confirms the specific mailbox accepts incoming messages, without sending a message. Phone validation confirms work phone numbers are active and matched to the provider record. Physical address validation covers both work practice addresses and home addresses, with records that fail validation removed and replaced in the next monthly refresh cycle.
NPI Taxonomy Codes
CMS NPI taxonomy codes for reference. These are useful when specifying subspecialty requirements for a data order or verifying provider credentials independently. SparkDBi cross-references these as one of several validation inputs:
| Taxonomy Code | Classification |
|---|---|
| 207RE0101X | Endocrinology, Diabetes and Metabolism (Internal Medicine subspecialty) |
| 207RR0500X | Reproductive Endocrinology and Infertility |
| 2080B0002X | Pediatric Endocrinology |
Practice Setting Breakdown
About 60% of endocrinologists in the SparkDBi database practice in hospital-based or academic medical centre settings. The remaining 40% are in private endocrinology groups, multispecialty clinics, and diabetes-focused outpatient centres. Academic endocrinologists carry the highest trial and research involvement, particularly for diabetes, obesity, and rare endocrine disorders.
SparkDBi can filter by practice setting and by affiliation with academic endocrinology programmes, diabetes centres, and fertility clinics.
Top 10 Hospitals for Endocrinology (2026 World Rankings)
Rankings from the Newsweek World's Best Specialized Hospitals 2026 report. SparkDBi maintains verified contact data for endocrinologists affiliated with each institution.
| Rank | Hospital | Location |
|---|---|---|
| #1 | Mayo Clinic - Rochester | Rochester, US |
| #2 | Massachusetts General Hospital | Boston, US |
| #3 | Cleveland Clinic | Cleveland, US |
| #4 | Asan Medical Center | Seoul, KR |
| #5 | Seoul National University Hospital | Seoul, KR |
| #6 | The Johns Hopkins Hospital | Baltimore, US |
| #7 | Charite - Universitatsmedizin Berlin | Berlin, DE |
| #8 | Mayo Clinic Hospital - Phoenix | Phoenix, US |
| #9 | Brigham and Women's Hospital | Boston, US |
| #10 | NewYork-Presbyterian Hospital - Columbia and Cornell | New York City, US |
Geographic and International Coverage
The US endocrinology database covers all 50 states. Highest concentrations are in California, Texas, New York, Florida, and Illinois, reflecting population density and the location of major academic diabetes and endocrinology programmes.
International endocrinology data is available for the UK, Germany, France, Canada, Australia, and South Korea. Contact SparkDBi for current counts by country.
Deliverability
Endocrinologists at academic medical centres and hospital systems use enterprise email environments with standard filtering from Proofpoint, Mimecast, or Microsoft Defender. Private-practice endocrinologists at diabetes clinics and reproductive endocrinology centres use practice-domain email with lighter filtering. SparkDBi flags enterprise vs independent domains in delivered datasets.
Data Enrichment and Available Fields
For existing contact lists, SparkDBi can append or verify: NPI numbers (where applicable), subspecialty classifications, hospital affiliations, email addresses, phone numbers, work practice addresses, home addresses, and personal email addresses. Match rates average 73% against the full database.
Compliance
The SparkDBi endocrinology email list email list contains no patient data. All records are professional contact information for licensed healthcare providers. The database is HIPAA-aligned, CAN-SPAM compliant, and CCPA-aware. Business Associate Agreements are available on request.